Comvita, the manuka honey health care manufacturer, says first-half profit will be the best in at least two years, and is pointing to an annual profit of as much as $8.2 million after last year's slump.
The Te Puke-based company expects to post a profit of $2.1 million on $41 million of sales in the six months ended September 30, beating the same performance in the past two years.
That doesn't include a US$1 million ($1.22 million) capital payment received this month from Derma Sciences.
That has the company on track for annual earnings of between $7.3 million and $8.2 million, with sales expected to be between $91 million and $95 million.
"With export sales now in excess of 80 per cent of total sales, Comvita remains committed to its global sales strategy," it said.
